Shareholders Equity: The sum of preferred and common equity items.
Regenicin Inc. (RGIN) had Shareholders Equity of $-5.60M for the most recently reported fiscal year, ending 2022-09-30.
| Income Statement Financials | |
-- |
|
$-0.69M |
|
-- |
|
-- |
|
$0.60M |
|
$-0.60M |
|
$-0.04M |
|
$-0.64M |
|
$-0.64M |
|
$-0.64M |
|
$-0.64M |
|
$-0.64M |
|
$-0.64M |
|
$-0.60M |
|
$-0.60M |
|
153.48M |
|
153.48M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.02M |
|
-- |
|
-- |
|
$0.02M |
|
$5.61M |
|
-- |
|
-- |
|
$5.61M |
|
$-5.60M |
|
$-5.60M |
|
|
Shareholders Equity |
$-5.60M |
153.48M |
|
| Cash Flow Statement Financials | |
$-0.03M |
|
-- |
|
$0.04M |
|
$0.00M |
|
$0.01M |
|
$0.01M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.03M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
11.42% |
|
11.42% |
|
-4126.13% |
|
11.42% |
|
$-0.04 |
|
$-0.00 |
|
$-0.00 |
|